Concepedia

Raphael R. Steimbach

RR

Statistics

Publications

16

Citations

576

H-Index

14

Active since

2019

Affiliations

German Cancer Research Center(Current)

Heidelberg University

Deutsches Konsortium für Translationale Krebsforschung

University of Pennsylvania

Technical University of Munich

Raphael R. Steimbach is an author at German Cancer Research Center specializing in pharmacology, enzyme inhibition, and histone deacetylases.

ORCID

Publications per year

2019–2025

16

Publications

16

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Severin Lechner, Martin Ian P. Malgapo, Christian Grätz et al. · Nature Chemical Biology · 2022 · 112 citations · Full text

, , +9

Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated

Magalie Géraldy, Michael Morgen, Peter Sehr et al. · Journal of Medicinal Chemistry · 2019 · 94 citations · Full text

, , +12

Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity

Xin Chen, Xinyang Chen, Raphael R. Steimbach et al. · European Journal of Medicinal Chemistry · 2019 · 48 citations · Full text

, , +17

Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout

Raphael R. Steimbach, Corey J. Herbst‐Gervasoni, Severin Lechner et al. · Journal of the American Chemical Society · 2022 · 43 citations · Full text

, , +16

Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine Deacetylase

Corey J. Herbst‐Gervasoni, Raphael R. Steimbach, Michael Morgen et al. · ACS Chemical Biology · 2020 · 41 citations · Full text

, , +16

1–5 of 16